Supplementation of conventional therapy with the novel grain salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: Results of a randomized controlled trial

Diabetes Care

Volumn 30, Issue 11, 2007, Pages 2804-2810

  Vuksan, Vladimir ^a,b   Whitham, Dana ^a,b   Sievenpiper, John L ^a,b   Jenkins, Alexandra L ^a   Rogovik, Alexander L ^a   Bazinet, Richard P ^b   Vidgen, Edward ^b   Hanna, Amir ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GLUCOSE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; LINOLEIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PIOGLITAZONE; SIMVASTATIN; VON WILLEBRAND FACTOR;

ARTICLE; BODY MASS; BODY WEIGHT; CANADA; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SALVIA HISPANICA; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WHEAT BRAN;

BLOOD GLUCOSE; BLOOD PRESSURE; BREAD; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CEREALS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIETARY FIBER; DIETARY SUPPLEMENTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INTERNATIONAL NORMALIZED RATIO; LIPIDS; PROTHROMBIN TIME; RISK FACTORS; SALVIA; SINGLE-BLIND METHOD;

EID: 36049022781     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1144     Document Type: Article

References (27)

1. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition: A food labeling guide [article online], 1994. Available from http://www.cfsan.fda.gov/~dms/flg-6c.html. Accessed 14 February 2007
2. Richardson DP: Wholegrain health claims in Europe. Proc Nutr Soc 62:161-169, 2003
3. Jenkins DJ, Wolever TM, Leeds AR, Gassull MA, Haisman P, Dilawari J, Goff DV, Metz GL, Alberti KG: Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1:1392-1394, 1978
4. Wolever TMS, Barbeau MC, Charron S, Harrington K, Leung S, Madrick B, Taillefer T, Stero C: Guidelines for the nutritional management of diabetes mellitus in the new millennium: a position by the Canadian Diabetes Association. CJDC 23:56-69, 2000
5. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157:2413-2446, 1997
6. Bazinet RP, McMillan EG, Cunnane SC: Dietary alpha-linolenic acid increases the n-3 PUFA content of sow's milk and the tissues of the suckling piglet. Lipids 38:1045-1049, 2003
7. Canadian Diabetes Association: Clinical practice guidelines expert committee: dyslipidemia in adults with diabetes. CJDC 30:230-240, 2006
8. Seal CJ: Whole-grains and CVD risk. Proc Nutr Soc 65:24-34, 2006
9. Finnegan YE, Minihane AM, Leigh-Firbank EC, Kew S, Meijer GW, Muggli R, Calder PC, Williams CM: Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 77:783-795, 2003
10. Harper CR, Jacobson TA: The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 161:2185-2192, 2001
11. Bazinet RP, Sievenpiper JL, Stavro PM, Cunnane SC, Vuksan V: Salvia hispanica L., a rich source of alpha-linolenic acid, prolongs postprandial glycemia. FASEB 15:A992, 2001
12. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD, Beilin LJ: Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71:1085-1094, 2000
13. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99:779-785, 1999
14. Suter PM, Sierro C, Vetter W: Nutritional factors in the control of blood pressure and hypertension. Nutr Clin Care 5:9-19, 2002
15. Bao DQ, Mori TA, Burke V, Puddey IB, Beilin LJ: Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives. Hypertension 32:710-717, 1998
16. Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88:523-533, 1993
17. Ridker PM: High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103:1813-1818, 2001
18. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J: Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 189:19-30, 2006
19. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM: Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134:2991-2997, 2004
20. Bemelmans WJ, Lefrandt JD, Feskens EJ, van Haelst PL, Broer J, Meyboom-de Jong B, May JF, Tervaert JW, Smit AJ: Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr 58:1083-1089, 2004
21. Satoh N, Shimatsu A, Kotani K, Sakane N, Yamada K, Suganami T, Kuzuya H, Ogawa Y: Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome. Diabetes Care 30:144-146, 2007
22. Rosenson RS, Koenig W: Utility of inflammatory markers in the management of coronary artery disease. Am J Cardiol 92:10i-8i, 2003
23. Wendland E, Farmer A, Glasziou P, Neil A: Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92:166-169, 2006
24. Vischer UM: von Willebrand factor, endothelial dysfunction, and cardiovascular disease. J Thromb Haemost 4:1186-1193, 2006
25. Allman-Farinelli MA, Hall D, Kingham K, Pang D, Petocz P, Favaloro EJ: Comparison of the effects of two low fat diets with different alpha-linolenic: linoleic acid ratios on coagulation and fibrinolysis. Atherosclerosis 142:159-168, 1999
26. Lox CD: The effects of dietary marine fish oils (omega-3 fatty acids) on coagulation profiles in men. Gen Pharmacol 21:241-246, 1990
27. Garg A, Bantle JP, Henry RR, Coulston AM, Griver KA, Raatz SK, Brinkley L, Chen YD, Grundy SM, Huet BA, Reaven GM: Effects of varying carbohydrate content of diet in patients with non-insulin-dependent diabetes. JAMA 271:1421-1428, 1994